MedTrace Logo

Inverted-T Incision With Early Apical Release vs. Three-Lobe in Holmium Laser Enucleation of The Prostate

NCT07642063 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-06-11

No results posted yet for this study

Summary

Aim of the work is to compare the surgical efficacy and perioperative outcomes of the inverted-T incision with early apical release technique versus the standard three-lobe technique in patients undergoing Holmium Laser Enucleation of The prostate for Benign prostatic hyperplasia .

Primary outcome :

* Technical operative time (started from the activation of the holmium laser for enucleation of the prostate lobes and ending after completion of morcellation )

Secondary outcome:

* Laser energy used.
* Intraoperative blood loss (change in hemoglobin level).
* Learning curve.

Conditions

  • Prostate
  • Benign Prostatic Hyperplasia (BPH)

Interventions

PROCEDURE

inverted-T with early apical release technique

Patients will undergo the inverted-T with early apical release technique. After a full-thickness incision is made at the 12 o'clock position, lateral horizontal incisions are made from the midline towards the sides, expanding the vertical incision to form the "T" shape. Then, early apical release is performed followed by dissection in the posterior plane. After that, the planes are conjoint with continued enucleation until the adenoma is totally separated.

PROCEDURE

standard three-lobe technique

Patients will undergo the standard three-lobe technique. After enucleation, adenoma will be morcellated in the bladder using a morcellator device. 3 way urethral catheter will be inserted at the end of the procedure. Laser settings, operative time and blood loss will be recorded for every case.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-20
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07642063 on ClinicalTrials.gov